Profile picture

Doctor Wern Yew Ding

University of Liverpool, Liverpool (United Kingdom of Great Britain & Northern Ireland)
Follow
Logo ESC

Contributor content

Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry
Presentation
Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry
Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry
Presentation
Incidence and risk factors for residual adverse events despite anticoagulation in atrial fibrillation: results from phase II/III of the GLORIA-AF registry
Clinical application of the novel 4S-AF scheme for the characterisation of patients with atrial fibrillation: a report from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
Presentation
Clinical application of the novel 4S-AF scheme for the characterisation of patients with atrial fibrillation: a report from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
Digoxin vs. beta-blocker therapy in atrial fibrillation: analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
Presentation
Digoxin vs. beta-blocker therapy in atrial fibrillation: analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
Stroke risk based on classification of atrial fibrillation: real-world vs clinical trial
Presentation
Stroke risk based on classification of atrial fibrillation: real-world vs clinical trial
Ablation Index-guided 50W radiofrequency ablation for atrial fibrillation: lesion level analysis to ascertain determinants of safety
Presentation
Ablation Index-guided 50W radiofrequency ablation for atrial fibrillation: lesion level analysis to ascertain determinants of safety
Novel tool for predicting residual stroke risk in atrial fibrillation: mCARS
Presentation
Novel tool for predicting residual stroke risk in atrial fibrillation: mCARS
Number needed to treat for net effect of anticoagulation in atrial fibrillation
Presentation
Number needed to treat for net effect of anticoagulation in atrial fibrillation

ESC 365 is supported by